PI
CLLS

Putnam Investments’s Cellectis CLLS Stock Holding History

Putnam Investments’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-40,000
Closed -$963K – 1255
2016
Q3 		$963K Hold
40,000
– – ﹤0.01% 1027
2016
Q2 		$1.06M Hold
40,000
– – ﹤0.01% 1092
2016
Q1 		$1.1M Hold
40,000
– – ﹤0.01% 1093
2015
Q4 		$1.24M Hold
40,000
– – ﹤0.01% 1107
2015
Q3 		$1.05M Hold
40,000
– – ﹤0.01% 1157
2015
Q2 		$1.44M Hold
40,000
– – ﹤0.01% 1138
2015
Q1 		$1.38M Buy
+40,000
New +$1.45M ﹤0.01% 1143

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Putnam Investments's CLLS Position: Q4 2016 in Review

Putnam Investments sold out of Cellectis (CLLS) in Q4 2016, closing a stake of 40,000 shares — an estimated $963K sold.

Putnam Investments first reported a position in CLLS in Q1 2015 and held it in 7 quarters. The position peaked at $1.44M in Q2 2015. 37 funds tracked by Wall St. Rank hold CLLS as of Q4 2016.

  • Putnam Investments reported no remaining Cellectis position as of Q4 2016 after selling out during the quarter.
  • Putnam Investments sold 40,000 Cellectis shares in Q4 2016, an estimated $963K.
  • Putnam Investments first reported a position in Cellectis in Q1 2015 and held it in 7 quarters.
  • Putnam Investments's Cellectis position peaked at $1.44M in Q2 2015.
  • 37 funds tracked by Wall St. Rank held Cellectis as of Q4 2016.

Based on Putnam Investments's 13F filing for Q4 2016, filed 14 Feb 2017.